SYSCO Corporation - Fortune Brands Inc - United Stationers Inc. - Sealed Air Corporation - Smithfield Foods, Inc.
 |
|
| |
What is 'Pawn Your Diamond'?
'Pawn Your Diamond' offers the community information
about the Fortune 500 companies.
Why the name?
The aim behind our name is to give young
entrepreneurs the incentive to start from scratch with
the hope that this small money they got from pawning a
diamond they had aside, grows and flourishes into a
multi billion dollar corporation.
Too dreamy?
Simply NOT. Such famous corporations did not exist
forever. Each and every foundation did start somewhere
and usually had one or a few founding members. So grab
the general concept and work hard!
|
|
|
| |
|
| |
Fortune 500 - Spot Number 212
Company Information
Name: Amgen Inc
Industry: Biotechnology & Drugs
Description: Amgen, Inc. is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. The Company manufactures and markets four human therapeutic products, EPOGEN (Epoetin alfa), NEUPOGEN (Filgrastim), INFERGEN (Interferon alfacon-1) and STEMGEN (Ancestim). Amgen uses wholesale distributors of pharmaceutical products as the principal means of distributing the Company's products to clinics, hospitals and pharmacies.
Financial Summary: For the nine months ended 30 September 2005, Amgen, Inc.'s revenues rose 20% to $9.16B. Net income rose 70% to $2.85B. Revenues reflect higher demand for Aranesp(R), ENBREL(R) and Neulasta(R). Net income benefited from decreased selling, general & administrative expenses as a percentage of revenues and the absence of write-off of acquired inprocess research & development expenses. The Company is engaged in manufacturing of human therapeutics.
Business Summary: Amgen Inc. (Amgen) is a global biotechnology company that discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology. It operates in one business segment: human therapeutics. Amgen markets human therapeutic products in the areas of nephrology, supportive cancer care and inflammatory disease. Its principal products include EPOGEN (Epoetin alfa), Aranesp (darbepoetin alfa), Neulasta (pegfilgrastim), NEUPOGEN (Filgrastim) and ENBREL (etanercept), which is marketed under a co-promotion agreement with Wyeth in the United States and Canada. Amgen markets its products to healthcare providers, including clinics, hospitals and pharmacies. The Company operates in the United States, Europe, Canada and Australia. On August 13, 2004, Amgen acquired Tularik Inc. (Tularik). Tularik was a company engaged in drug discovery related to cell signaling and the control of gene expression.
Misc Details
Symbol: AMGN
City: Thousand Oaks
State: CA
ZIP Code: 91320
Address: One Amgen Centre Drive
Phone: 805-447-1000
Fax: 805-447-1010
Website: http://www.amgen.com
|
| |
|
| |
|
Mutual of Omaha - Marathon Oil Corp. - ConAgra Foods, Inc. - Aramark Corporation - Caterpillar Inc. |